Mayo Clinic

Type

Corporate investor

Status

Active

Location

Rochester, United States

Total investments

85

Average round size

29M

Portfolio companies

67

Rounds per year

0.81

Lead investments

6

Follow on index

0.21

Exits

6

Areas of investment
BiotechnologySoftwareArtificial IntelligenceHealth CareHealth DiagnosticsWellnessMedical DeviceMedicalPharmaceuticalTherapeutics

Summary

Mayo Clinic appeared to be the Corporate Investor, which was created in 1919. The main department of described Corporate Investor is located in the Rochester. The company was established in North America in United States.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Mayo Clinic, startups are often financed by Canaan Partners, Social Capital, Three Arch Partners. The meaningful sponsors for the fund in investment in the same round are Three Arch Partners, MPM Capital, Bay City Capital. In the next rounds fund is usually obtained by Venrock, Three Arch Partners, Sands Capital Ventures.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Artificial Intelligence. Among the most popular portfolio startups of the fund, we may highlight Helix, DayTwo, AliveCor. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low.

The current fund was established by Augustus Stinchfield, Charles Horace Mayo, Christopher Graham, Donald Balfou, Henry Stanley Plummer, Melvin Millet, William James Mayo. We also calculated 8 valuable employees in our database.

The higher amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this Corporate Investor is 8 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2014. Despite it in 2019 the fund had an activity. The average startup value when the investment from Mayo Clinic is 50-100 millions dollars. This Mayo Clinic works on 17 percentage points less the average amount of lead investments comparing to the other organizations.

Show more

Investor highlights

Stage focus
Seed

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
85
Lead investments
6
Exits
6
Rounds per year
0.81
Follow on index
0.21
Investments by industry
  • Health Care (56)
  • Biotechnology (32)
  • Medical (24)
  • Health Diagnostics (17)
  • Medical Device (16)
  • Show 61 more
Investments by region
  • United States (76)
  • Israel (1)
  • Switzerland (1)
  • China (1)
  • South Korea (1)
  • Show 4 more
Peak activity year
2023

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
12M
Group Appearance index
0.88
Avg. company exit year
6
Avg. multiplicator
1.95
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
MEDIVIS 13 Jun 2023 Health Care, Medical, Augmented Reality, Data Visualization Early Stage Venture 20M United States, New York, New York
Nucleus RadioPharma 05 Jun 2024 Health Care Early Stage Venture United States, New York, Rochester
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.